Surzebiclimab
Clivatuzumab
Sontuzumab
Minretumomab
Gatipotuzumab
Ensituximab
MUC1, mucin core
MUC5AC motif peptide
Gefarnate
Guaifenesin
Ac5GalNTGc
Ac5GalNTGc epimer
Eudragit RS 100
Tasuldine